WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004029616) METHODS FOR DETECTING PROSTATE CANCER
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/029616    International Application No.:    PCT/CA2003/001479
Publication Date: 08.04.2004 International Filing Date: 26.09.2003
IPC:
G01N 33/50 (2006.01), G01N 33/574 (2006.01)
Applicants: MOUNT SINAI HOSPITAL [CA/CA]; 600 University Avenue, Toronto, Ontario M5G 1X5 (CA) (For All Designated States Except US).
DIAMANDIS, Eleftherios, P. [CA/CA]; (CA) (For US Only)
Inventors: DIAMANDIS, Eleftherios, P.; (CA)
Agent: KURDYDYK, Linda; McCarthy Tetrault, Suite 4700, P.O. Box 48, 66 Wellington Street West, Toronto Dominion Bank Tower, Toronto, Ontario M5K 1E6 (CA)
Priority Data:
60/414,314 26.09.2002 US
Title (EN) METHODS FOR DETECTING PROSTATE CANCER
(FR) METHODES DE DETECTION DU CANCER DE LA PROSTATE
Abstract: front page image
(EN)The invention relates to the application of kallikrein (11), free PSA, and total PSA in the detection of prostate cancer. These markers may be used for the diagnosis, monitoring, staging, progression, prevention, treatment, and prognosis of prostate cancer, and as indicators before surgery or after relapse. A particular aspect of the invention provides a method for distinguishing prostate cancer from benign prostatic hyperplasia (BPH).
(FR)L'invention concerne l'application de kallicréine 11, d'antigène prostatique spécifique (PSA) libre et d'antigène prostatique spécifique (PSA) total dans la détection du cancer de la prostate. Ces marqueurs peuvent être utilisés dans le diagnostic, la surveillance, le bilan d'extension, la progression, la prévention, le traitement et le pronostic du cancer de la prostate et en tant qu'indicateurs avant une intervention chirurgicale ou après une rechute. Un aspect spécifique de l'invention a trait à une méthode de distinction du cancer de la prostate d'une hyperplasie prostatique bénigne.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)